Options for transplant-eligible patients

What’s new in transplant-eligible newly diagnosed multiple myeloma?

Dr Niels Van de Donk and Dr Karthik Ramasamy discuss recent updates from a number of clinical studies investigating novel upfront regimens, consolidation and maintenance therapy options, as well as the potential for tandem and allograft transplantation in the management of newly diagnosed multiple myeloma patients.

The views expressed in the video are those of the speakers.

UK/NP/1806/0035an - August 2018

You are now leaving the Myeloma Hub

This link opens another website that is not under the review or control of Takeda UK Ltd and, as such, the company does not endorse the content, its accuracy, or any practices or standards contained within it. Please confirm you wish to continue.